KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $3.8 billion.

  • Edwards Lifesciences' Cash & Current Investments fell 1358.72% to $3.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 billion, marking a year-over-year decrease of 1358.72%. This contributed to the annual value of $4.0 billion for FY2024, which is 14350.2% up from last year.
  • According to the latest figures from Q3 2025, Edwards Lifesciences' Cash & Current Investments is $3.8 billion, which was down 1358.72% from $4.1 billion recorded in Q2 2025.
  • In the past 5 years, Edwards Lifesciences' Cash & Current Investments registered a high of $4.4 billion during Q3 2024, and its lowest value of $1.2 billion during Q4 2022.
  • In the last 5 years, Edwards Lifesciences' Cash & Current Investments had a median value of $1.7 billion in 2024 and averaged $2.2 billion.
  • Per our database at Business Quant, Edwards Lifesciences' Cash & Current Investments plummeted by 1765.75% in 2022 and then soared by 14350.2% in 2024.
  • Edwards Lifesciences' Cash & Current Investments (Quarter) stood at $1.5 billion in 2021, then dropped by 17.66% to $1.2 billion in 2022, then soared by 35.19% to $1.6 billion in 2023, then soared by 143.5% to $4.0 billion in 2024, then fell by 3.37% to $3.8 billion in 2025.
  • Its Cash & Current Investments was $3.8 billion in Q3 2025, compared to $4.1 billion in Q2 2025 and $3.9 billion in Q1 2025.